25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

duce variably inhibitory or activating signals after binding to MHC class I or Ib molecules.<br />

The absence of MHC expression may trigger NK cell activation.<br />

Neutrophil<br />

A phagocytic polymorphonuclear leukocyte that can ingest <strong>and</strong> kill invading microorganisms.<br />

They play important parts in inflammatory reactions both in the removal<br />

of microorganisms <strong>and</strong> aged <strong>and</strong> damaged cells, <strong>and</strong> as a source for inflammatory<br />

agents such as chemokines, cytokines, leukotrienes <strong>and</strong> other lipid mediators of inflammation.<br />

Suicide gene<br />

Inducible gene that codes for a protein which mediates cell death. One of the bestknown<br />

examples is the herpes simplex virus thymidine kinase (HSV-tk) which converts<br />

the non-toxic prodrug gancyclovir into its cytotoxic phosphorylated form.<br />

Programmed cell death<br />

see Apoptosis.<br />

Glossary<br />

T cell receptor (TCR)<br />

Antigen receptor of T lymphocytes. The TCR consists of a disulfide-bonded ab or gd<br />

heterodimer expressed at the cell surface in association with the CD3 molecular<br />

complex as the signal-transducing unit of the receptor. The genes for the TCR are rearranged<br />

from the germline V, D, <strong>and</strong> J elements during the ontology of the T lymphocyte<br />

to form the clonotypic genes <strong>and</strong> gene products. The lig<strong>and</strong>s of the TCR are<br />

MHC/peptide complexes.<br />

T lymphocyte (T cell)<br />

Lymphocyte of the thymic linage which are subdivided into CD8-expressing cytolytic<br />

T lymphocytes (CTL) <strong>and</strong> CD4-expressing regulatory helper T cells. The precursors of T<br />

cells originate in the bone marrow <strong>and</strong> migrate as CD4/CD8 double-positive cells<br />

into the thymus where they differentiate into the mature T lymphocyte types. During<br />

thymic differentiation, the T cell receptor (TCR) genes are rearranged. T cells are<br />

selected to propagate whose TCR are MHC-restricted (positive selection) <strong>and</strong> are<br />

eliminated <strong>by</strong> apoptosis when they bind MHC/peptide complexes with high affinity;<br />

thus, they are potentially autoreactive (negative selection, see Central tolerance). T<br />

cells as regulator <strong>and</strong> effector T cells are key instruments of the adaptive immune<br />

system. Unlike B lymphocytes, T lymphocytes recognize their epitopes as complexes<br />

with MHC class I or I molecules.<br />

T body<br />

Cytotoxic T lymphocyte genetically engineered to express a chimeric antibody/receptor<br />

surface molecule with specificity for an antigen on the surface of tumor cells.<br />

Usually the chimeric receptor consists of single-chain antibody fragments with the<br />

desired specificity fused to CD3z or Fc receptor g as signal transduction domains.<br />

T bodies have been developed with a number of different specificities. Anti-G250<br />

391

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!